Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab can be used for the research of chronic spontaneous urticarial.
Purity:
>99.0%
CAS Number:
[1322627-61-1]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted